| View |
|
DR-XY48680
|
Mycophenolate Mofetil
|
Mycept
|
250 mg
|
Capsule
|
-
|
Panacea Biotec Ltd.
|
India
|
Initial (Reconstruction)
|
03 August 2023
|
29 March 2028
|
| View |
|
DRP-13666
|
Ferrous sulfate + Folic Acid + Pyridoxine hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Saphfovit-fe
|
187 mg (equivalent to 60 mg Elemental Iron) +
600 mcg + 20 mg + 25 mcg
|
Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
|
Initial
|
23 March 2023
|
23 March 2028
|
| View |
|
DR-XY48669
|
Lenalidomide
|
Lenalid 5
|
5 mg
|
Capsule
|
-
|
Natco Pharma Limited Pharma Division
(Unit IV and V)
|
|
Monitored Release
|
27 March 2023
|
27 March 2028
|
| View |
|
DR-XY48668
|
Lenalidomide
|
Lenalid 10
|
10 mg
|
Capsule
|
-
|
Natco Pharma Limited Pharma Division
(Unit IV and V)
|
|
Monitored Release
|
27 March 2023
|
27 March 2028
|
| View |
|
DR-XY48667
|
Lenalidomide
|
Lenalid 15
|
15 mg
|
Capsule
|
-
|
Natco Pharma Limited Pharma Division
(Unit IV and V)
|
|
Monitored Release
|
27 March 2023
|
27 March 2028
|
| View |
|
DR-XY48666
|
Lenalidomide
|
Lenalid 25
|
25 mg
|
Capsule
|
-
|
Natco Pharma Limited Pharma Division
(Unit IV and V)
|
|
Monitored Release
|
27 March 2023
|
27 March 2028
|
| View |
|
DRP-13637
|
Rivaroxaban
|
Roxab
|
15mg
|
Film-Coated Tablet
|
-
|
Eskayef Pharmaceuticals Limited
|
|
Initial
|
22 March 2023
|
22 March 2028
|
| View |
|
DRP-13638
|
Rivaroxaban
|
Roxab
|
10 mg
|
Film-Coated Tablet
|
-
|
Eskayef Pharmaceuticals Limited
|
|
Initial
|
22 March 2023
|
22 March 2028
|
| View |
|
DRP-13633
|
Ascorbic Acid + Zinc
|
Xtracee Plus Chewtab
|
250 mg (equivalent to 281.25 mg Ascorbate)/15 mg (equivalent to 105 mg Zinc Gluconate)
|
Chewable Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
|
Initial
|
21 March 2023
|
21 March 2028
|
| View |
|
DRP-13671
|
Ascorbic Acid + Zinc
|
Xtracee Plus® Ct
|
250 mg (equivalent to 281.25 mg Sodium Ascorbate)/ 5 mg (equivalent to 35 mg Zinc Gluconate)
|
Chewable Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
|
Initial
|
24 March 2023
|
24 March 2028
|
| View |
|
DRP-13661
|
Ketoconazole
|
Kenz Cream
|
20mg/g (2% w/w/)
|
Cream
|
-
|
KLM Laboratories Pvt. Ltd.
|
|
Initial [OTC]
|
29 March 2023
|
29 March 2028
|
| View |
|
DRP-13644
|
Rivaroxaban
|
Brelta 10
|
10 mg
|
Film-Coated Tablet
|
-
|
Inventia Healthcare Limited
|
|
Initial
|
22 March 2023
|
22 March 2028
|
| View |
|
DRP-13643
|
Rivaroxaban
|
Brelta 20
|
20mg
|
Film-Coated Tablet
|
-
|
Inventia Healthcare Limited
|
|
Initial
|
22 March 2023
|
22 March 2028
|
| View |
|
DRP-13658
|
Ambroxol Hydrochloride
|
Ambrolyte
|
30mg
|
Tablet
|
-
|
Globela Pharma Private Limited
|
|
Initial [OTC]
|
29 March 2023
|
29 March 2028
|
| View |
|
DRP-13652
|
Paracetamol
|
Bmol
|
500 mg
|
Tablet
|
-
|
Rhydburg Pharmaceuticals Limited.
|
|
Initial [OTC]
|
24 March 2023
|
24 March 2028
|
| View |
|
DRP-13636
|
Rivaroxaban
|
Roxab
|
20 mg
|
Film-Coated Tablet
|
-
|
Eskayef Pharmaceuticals Limited
|
|
Initial
|
22 March 2023
|
22 March 2028
|
| View |
|
DRP-13660
|
Mupirocin
|
Busid
|
20 mg/g (2% w/w)
|
Ointment
|
-
|
Rhydburg Pharmaceuticals Limited
|
|
Initial [OTC]
|
29 March 2023
|
29 March 2028
|
| View |
|
DRP-13659
|
Mupirocin
|
Bupiron
|
20 mg/g (2% w/w)
|
Ointment
|
-
|
Rhydburg Pharmaceuticals Limited
|
|
Initial [OTC]
|
29 March 2023
|
29 March 2028
|
| View |
|
DR-XY48676
|
Rivaroxaban
|
Varoxan
|
20 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
|
Initial
|
29 March 2023
|
29 March 2028
|
| View |
|
DR-XY48677
|
Rivaroxaban
|
Varoxan
|
15 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
|
Initial
|
29 March 2023
|
29 March 2028
|